Magnetic
Resonance -
Technology
Information
Portal |
Welcome to MRI Technology• |
|
|
| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | | | |
| | |
|
| |
| The primary login terminal on the host computer used to start software. | | | | | | | |
|
| |
|
Contact Information
MAIL
Bornhop Research Group
MS 1061 Dept of Chemistry and Biochemistry
Texas Tech University
Lubbock, TX 79409
USA
PHONE
Office Phone: +1-806-742-3142
Lab Phone: +1-806-742-3152
| | | | | | | | | | | | |
|
| |
|
The company is a member of the Bracco Group, a highly innovative healthcare group and world leader in global integrated solutions for the diagnostic medical imaging field. The Bracco Group is headquartered in Milan, Italy. Its North American operations consist of Bracco Diagnostics and Bracco Research USA, both located in Princeton, New Jersey. Bracco Diagnostics is one of the fastest growing developers and marketers of diagnostic pharmaceuticals in North America, with products for various imaging applications, including Isovue® (iopamidol - X-ray contrast agent), ProHance® ( gadoteridol - MRI contrast agent), SonoVue® ( ultrasound contrast agent) and nuclear medicine products.
Gadoteridol has been available in Europe and the USA for several years.
Holder of the Marketing Authorization:
Bracco International B.V. - Strawinskylaan 3051 - 1077 ZX Amsterdam
The Netherlands. (Contact: Kirk Deeter, Phone: +NL-303-838-8708)
MRI Contrast Agents:
Contact Information
Please see Bracco Diagnostics, Inc.'s
| | | | • View the DATABASE results for 'Bracco Diagnostics, Inc.' (2).
| | | | Further Reading: | News & More:
|
|
| | | |
|
| |
| Eisai Co., Ltd. (Tokyo, Japan, President: Haruo Naito) and Bracco-Eisai Co., Ltd. (Tokyo, Japan, President: Toshio Matsumoto) decided to withdraw the new drug application (NDA) of E7155 (gadobenate meglumine), since new indications are emerging for the product and additional clinical data was necessary to complete the targeting product competitive risk/benefit profile. The product is currently marketed in other countries, and both companies are discussing a future development plan in Japan.
MRI Contrast Agents:
Contact Information
MAIL
Bracco Eisai Co., Ltd.
2-6, Kohinata 4-chome, Bunkyo-ku, Tokyo, 112-0006
| | | | • View the DATABASE results for 'Bracco-Eisai Co., Ltd.' (2).
| | | | | | | | | |
| | |
|
| |
| Look Ups |
| |
|
MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies. | | [last update: 2024-02-26 03:41:00] |
|
|